A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)

Author:

Okumura Yasuo1,Fukuda Ikuo2,Nakamura Mashio3,Yamada Norikazu4,Takayama Morimasa5,Maeda Hideaki6,Yamashita Takeshi7,Ikeda Takanori8,Mo Makoto9,Kobayashi Takao10,Niwa Akihiro11,Matsuo Hiroshi12,Yokoi Hiroyoshi13,Koga Masatoshi14,Yamazaki Tsutomu15,Hirayama Atsushi1,

Affiliation:

1. Division of Cardiology, Department of Medicine, Nihon University School of Medicine

2. Department of Cardiovascular Surgery, Hirosaki University

3. Nakamura Medical Clinic

4. Department of Cardiology, Kuwana City Medical Center

5. Department of Cardiology, Sakakibara Heart Institute

6. Division of Cardiovascular Surgery, Nihon University School of Medicine

7. Department of Cardiovascular Medicine, The Cardiovascular Institute

8. Department of Cardiovascular Medicine, Toho University Faculty of Medicine

9. Department of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital

10. Hamamatsu Medical Center

11. Hiratsuka Kyosai Hospital

12. Matsuo Clinic

13. Department of Cardiology, Fukuoka Sanno Hospital

14. Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center

15. Innovation and Research Support Center, International University of Health and Welfare

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3